vs
Side-by-side financial comparison of Borealis Foods Inc. (BRLS) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $7.1M, roughly 1.3× Borealis Foods Inc.). Borealis Foods Inc. runs the higher net margin — -53.2% vs -59.5%, a 6.3% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -12.0%). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -2.4%).
Borealis Foods Inc is a food technology enterprise specializing in developing and producing high-quality plant-based protein products including plant-based meat alternatives. It mainly serves retail and food service customers across North America and Europe, focusing on delivering affordable, nutritious sustainable food options matching the taste of conventional animal-derived meat.
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
BRLS vs CTSO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.1M | $9.2M |
| Net Profit | $-3.8M | $-5.5M |
| Gross Margin | 14.6% | 73.7% |
| Operating Margin | -27.1% | -47.5% |
| Net Margin | -53.2% | -59.5% |
| Revenue YoY | -12.0% | 0.9% |
| Net Profit YoY | 21.8% | 27.4% |
| EPS (diluted) | $-0.18 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $9.2M | ||
| Q3 25 | $7.1M | $9.5M | ||
| Q2 25 | $7.2M | $9.6M | ||
| Q1 25 | $6.8M | $8.7M | ||
| Q4 24 | $6.8M | $9.2M | ||
| Q3 24 | $8.1M | $8.6M | ||
| Q2 24 | $5.5M | $8.8M | ||
| Q1 24 | $7.9M | $9.0M |
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-3.8M | $-3.2M | ||
| Q2 25 | $-4.6M | $1.9M | ||
| Q1 25 | $-4.2M | $-1.5M | ||
| Q4 24 | $-5.8M | $-7.6M | ||
| Q3 24 | $-4.8M | $-2.8M | ||
| Q2 24 | $-6.3M | $-4.3M | ||
| Q1 24 | $-8.4M | $-6.1M |
| Q4 25 | — | 73.7% | ||
| Q3 25 | 14.6% | 70.3% | ||
| Q2 25 | 7.2% | 70.9% | ||
| Q1 25 | 13.1% | 71.1% | ||
| Q4 24 | 3.7% | 68.4% | ||
| Q3 24 | 15.8% | 61.0% | ||
| Q2 24 | 7.7% | 73.5% | ||
| Q1 24 | 3.1% | 76.5% |
| Q4 25 | — | -47.5% | ||
| Q3 25 | -27.1% | -30.2% | ||
| Q2 25 | -46.7% | -37.6% | ||
| Q1 25 | -42.6% | -44.5% | ||
| Q4 24 | -68.4% | -37.1% | ||
| Q3 24 | -44.8% | -56.1% | ||
| Q2 24 | -94.8% | -40.4% | ||
| Q1 24 | -88.3% | -51.8% |
| Q4 25 | — | -59.5% | ||
| Q3 25 | -53.2% | -33.4% | ||
| Q2 25 | -64.0% | 20.2% | ||
| Q1 25 | -61.2% | -16.9% | ||
| Q4 24 | -85.3% | -82.7% | ||
| Q3 24 | -59.8% | -32.1% | ||
| Q2 24 | -115.0% | -48.6% | ||
| Q1 24 | -106.8% | -67.7% |
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.18 | $-0.05 | ||
| Q2 25 | $0.21 | $0.03 | ||
| Q1 25 | $-0.20 | $-0.02 | ||
| Q4 24 | $-0.82 | $-0.14 | ||
| Q3 24 | $-0.23 | $-0.05 | ||
| Q2 24 | $0.29 | $-0.08 | ||
| Q1 24 | $-0.49 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $6.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-12.9M | $5.9M |
| Total Assets | $56.3M | $44.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | — | $5.9M | ||
| Q3 25 | $-12.9M | $9.0M | ||
| Q2 25 | $-9.2M | $11.6M | ||
| Q1 25 | $-4.8M | $14.5M | ||
| Q4 24 | $-695.9K | $11.1M | ||
| Q3 24 | $5.1M | $13.4M | ||
| Q2 24 | $9.9M | $17.4M | ||
| Q1 24 | $16.2M | $19.6M |
| Q4 25 | — | $44.2M | ||
| Q3 25 | $56.3M | $45.8M | ||
| Q2 25 | $57.3M | $48.0M | ||
| Q1 25 | $58.4M | $50.8M | ||
| Q4 24 | $60.0M | $47.4M | ||
| Q3 24 | $61.9M | $47.8M | ||
| Q2 24 | $63.6M | $53.4M | ||
| Q1 24 | $70.3M | $47.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-190.6K | $-4.8M |
| Free Cash FlowOCF − Capex | — | $-4.9M |
| FCF MarginFCF / Revenue | — | -53.4% |
| Capex IntensityCapex / Revenue | — | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.8M | ||
| Q3 25 | $-190.6K | $-2.6M | ||
| Q2 25 | $-2.2M | $-1.5M | ||
| Q1 25 | $-1.4M | $-3.5M | ||
| Q4 24 | $-819.4K | $-2.3M | ||
| Q3 24 | $-3.3M | $-2.5M | ||
| Q2 24 | $-4.2M | $-4.8M | ||
| Q1 24 | $-6.8M | $-4.8M |
| Q4 25 | — | $-4.9M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-1.4M | $-3.5M | ||
| Q4 24 | $-951.6K | $-2.4M | ||
| Q3 24 | $-3.7M | $-2.6M | ||
| Q2 24 | $-4.7M | $-4.8M | ||
| Q1 24 | $-7.3M | $-4.9M |
| Q4 25 | — | -53.4% | ||
| Q3 25 | — | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | -20.3% | -39.7% | ||
| Q4 24 | -14.1% | -26.3% | ||
| Q3 24 | -46.1% | -30.4% | ||
| Q2 24 | -86.7% | -54.4% | ||
| Q1 24 | -92.7% | -54.2% |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | 2.0% | 0.8% | ||
| Q3 24 | 5.6% | 1.8% | ||
| Q2 24 | 9.4% | 0.2% | ||
| Q1 24 | 7.0% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRLS
Segment breakdown not available.
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
